Skip to content

Contacts

FacebookTwitter
  • it
  • en
Fism Onlus
Fism Onlus
FISM รจ la Fondazione Italiana per le Sindromi Mielodisplastiche
  • About Fism
    • Mission
    • Structure
    • Statute
  • MDS and Therapies
    • Myelodysplastic Syndromes
      • Myelodysplastic Syndromes
      • Causes
      • Symptoms
      • Diagnostic Test
      • MDS Classification
      • Prognostic System
    • Therapies
      • Observation
      • Therapies According to Clinical Practice
      • Experimental Therapies
  • FISM Centers
  • FISM Registry
  • Research
    • Harmony
    • Research projects
      • Ongoing studies
        • AISSM06 DECI2009
        • FISM-hMDS
        • GFM-DAC-CMML
        • FISM-BIOFER12
      • Closed Studies
        • AISSM04 EPO2006
        • MDS ATO-AISSM02A
  • Meetings & Events
    • FISM Congresses
    • Sponsored Events
  • Donate
    • Donation online
    • Bank Transfer
    • Donation in memory
    • Regular Donation
    • Give your 5xMille
    • Fiscal Benefits
  • News
    • Insights
  • About Fism
    • Mission
    • Structure
    • Statute
  • MDS and Therapies
    • Myelodysplastic Syndromes
      • Myelodysplastic Syndromes
      • Causes
      • Symptoms
      • Diagnostic Test
      • MDS Classification
      • Prognostic System
    • Therapies
      • Observation
      • Therapies According to Clinical Practice
      • Experimental Therapies
  • FISM Centers
  • FISM Registry
  • Research
    • Harmony
    • Research projects
      • Ongoing studies
        • AISSM06 DECI2009
        • FISM-hMDS
        • GFM-DAC-CMML
        • FISM-BIOFER12
      • Closed Studies
        • AISSM04 EPO2006
        • MDS ATO-AISSM02A
  • Meetings & Events
    • FISM Congresses
    • Sponsored Events
  • Donate
    • Donation online
    • Bank Transfer
    • Donation in memory
    • Regular Donation
    • Give your 5xMille
    • Fiscal Benefits
  • News
    • Insights
  • C. F. 9 6 0 3 9 7 2 0 0 6 3
  • Fism Centers

  • Fism Registry

  • Mission

  • Structure

  • Help FISM

FISM is the Italian Foundation of Myelodysplastic Syndromes

FISM coordinates research activities on myelodysplasic syndromes in Italy from many centers distributed throughout the country.

Newsletter

What about Myelodysplastic Syndromes

The term “myelodysplasia” comes from the Greek words: “myelo”, that is, blood cells, and “dysplasia”, ie abnormal growth or growth.

Myelodysplastic syndromes (MDS) are a heterogeneous group of blood pathologies where bone marrow cells can not become perfect and healthy cells but stop at an immature stage. The bone marrow therefore fails to produce enough red blood cells, white blood cells or healthy platelets.

These cells that remain at an immature stage are called “blasts”.

The incidence of this disease in Europe is about 8 people per 100,000 inhabitants. This is a disease affecting mainly elderly people: over 70, people affected by MDS are about 35 people per 100,000 inhabitants.

Most experts agree that myelodysplasies are a type of bone marrow and bone marrow that can occur in either chronic or aggressive form.

Read More

What can you do?

To continue our job to a future free  from myelodysplasia, we need the help of everyone, even yours! Contribute to the scientific research that FISM brings forward every day, helps FISM to give to the patients a world where MDS are no longer scary.

Donazioni in memoria
Donazioni in memoria

Friend Links

logo_ail
aamds
ehaweb
mds-foundation
logo-aifa
logo-esh
logo-clinical
ministero
epicin
emsco
GFM logo
logo_siem
logo_sies
logo italian MDS network

News

October 25, MDS World Awareness Day
26 October 2018
Defeating anaemia in myelodysplastic syndromes: another step forward with Luspatercept
16 October 2017
Prof. Valeria Santini, FISM President, talks about Myelodysplastic Syndromes in this video realized by Aplastic Anemia & MDS Foundation
13 October 2017

Congresses and Events

No event found!
Fism Onlus
FISM Onlus - Piazza Turati 5 - 15121 Alessandria - C.F.: 96039720063 | Partita IVA: 02179990060

Policy Privacy | Credits